Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Latest From LG Chem, Ltd.

How Much Should Governments Pay For COVID-19 Monoclonal Antibody Therapies?

US government’s $450m manufacturing commitment for Regeneron’s antibody cocktail and Gilead’s price for remdesivir drive lower expectations on pricing for the antibody treatments, especially since it seems likely there could be several competing products.

Coronavirus COVID-19 Pricing Strategies

How Much Should Governments Pay For COVID-19 Monoclonal Antibody Therapies?

US government’s $450m manufacturing commitment for Regeneron’s antibody cocktail and Gilead’s price for remdesivir drive lower expectations on pricing for the antibody treatments, especially since it seems likely there could be several competing products.

Coronavirus COVID-19 Pricing Strategies

Vir/GSK Move Lead Coronavirus Antibody Into Phase III

Results from a Phase II/III study for VIR-7831 in the prevention of hospitalization due to COVID-19 are expected in late 2020 and early 2021.

Research and Development Strategies Coronavirus COVID-19

Lilly Claims Proof Of Concept For Neutralizing Antibodies In COVID-19 Therapy

Analysts called the interim data from a Phase II study of LY-CoV555 mixed, but Lilly insists that it has demonstrated a therapeutic role for neutralizing antibodies in fighting the novel coronavirus.

Coronavirus COVID-19 Clinical Trials
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Vaccines
  • Other Names / Subsidiaries
    • LG LI
UsernamePublicRestriction

Register